Actovegin vs GHK-Cu
Overview
Actovegin and GHK-Cu are both pain management peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Actovegin and GHK-Cu across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Actovegin | GHK-Cu | |
|---|---|---|
| Category | Pain Management | Pain Management |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 5-10 ml | 1-3 mg |
| Frequency | multiple weekly | daily |
| Reported benefits | Circulation-related pain relief, tissue oxygenation, healing support | Pain reduction through healing, anti-inflammatory, tissue regeneration |
| Reported side effects | Rare allergic reactions | Minimal side effects |
Key differences
Primary use. Actovegin is categorised under Pain Management, while GHK-Cu falls under Pain Management. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Actovegin: not FDA-approved; treated as a research compound. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Actovegin is typically dosed at 5-10 ml (multiple weekly). GHK-Cu is typically dosed at 1-3 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Actovegin and GHK-Cu has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Actovegin and GHK-Cu?
- Actovegin and GHK-Cu are both pain management peptides, but they differ in mechanism, dosing, and regulatory status. Actovegin is not FDA-approved; generally classified as a research compound, whereas GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Actovegin used for?
- Hypoxic pain and healing.
- What is GHK-Cu used for?
- Anti-inflammatory tissue repair.
- Can you take Actovegin and GHK-Cu together?
- Some users combine peptides within a single protocol, but stacking Actovegin and GHK-Cu has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Actovegin or GHK-Cu FDA-approved?
- Actovegin is not FDA-approved; generally classified as a research compound. GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).